| Product Code: ETC9977367 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Sufentanil Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Sufentanil Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Sufentanil Market - Industry Life Cycle |
3.4 United States (US) Sufentanil Market - Porter's Five Forces |
3.5 United States (US) Sufentanil Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 United States (US) Sufentanil Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 United States (US) Sufentanil Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 United States (US) Sufentanil Market Revenues & Volume Share, By Doses, 2021 & 2031F |
3.9 United States (US) Sufentanil Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.10 United States (US) Sufentanil Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Sufentanil Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic pain conditions in the US |
4.2.2 Growing adoption of sufentanil due to its high potency and effectiveness in pain management |
4.2.3 Rising awareness and acceptance of opioid analgesics in healthcare settings |
4.3 Market Restraints |
4.3.1 Stringent regulations and guidelines surrounding the use of opioids in the US |
4.3.2 Concerns about the potential for abuse and addiction associated with sufentanil |
4.3.3 Competition from alternative pain management therapies such as non-opioid medications and non-pharmacological interventions |
5 United States (US) Sufentanil Market Trends |
6 United States (US) Sufentanil Market, By Types |
6.1 United States (US) Sufentanil Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Sufentanil Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 United States (US) Sufentanil Market Revenues & Volume, By Opioid Analgesic, 2021- 2031F |
6.1.4 United States (US) Sufentanil Market Revenues & Volume, By Anaesthetic, 2021- 2031F |
6.2 United States (US) Sufentanil Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Sufentanil Market Revenues & Volume, By Intravenous Route, 2021- 2031F |
6.2.3 United States (US) Sufentanil Market Revenues & Volume, By Epidural Route, 2021- 2031F |
6.2.4 United States (US) Sufentanil Market Revenues & Volume, By Sublingual Route, 2021- 2031F |
6.3 United States (US) Sufentanil Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Sufentanil Market Revenues & Volume, By Branded, 2021- 2031F |
6.3.3 United States (US) Sufentanil Market Revenues & Volume, By Generic, 2021- 2031F |
6.4 United States (US) Sufentanil Market, By Doses |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Sufentanil Market Revenues & Volume, By Adult, 2021- 2031F |
6.4.3 United States (US) Sufentanil Market Revenues & Volume, By Pediatrics, 2021- 2031F |
6.4.4 United States (US) Sufentanil Market Revenues & Volume, By Geriatric, 2021- 2031F |
6.5 United States (US) Sufentanil Market, By End Users |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Sufentanil Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 United States (US) Sufentanil Market Revenues & Volume, By Clinics, 2021- 2031F |
6.5.4 United States (US) Sufentanil Market Revenues & Volume, By Other, 2021- 2031F |
6.6 United States (US) Sufentanil Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 United States (US) Sufentanil Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 United States (US) Sufentanil Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 United States (US) Sufentanil Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 United States (US) Sufentanil Market Import-Export Trade Statistics |
7.1 United States (US) Sufentanil Market Export to Major Countries |
7.2 United States (US) Sufentanil Market Imports from Major Countries |
8 United States (US) Sufentanil Market Key Performance Indicators |
8.1 Prescription rates of sufentanil by healthcare providers |
8.2 Patient satisfaction and pain relief outcomes with sufentanil treatment |
8.3 Number of clinical trials and research studies on new applications or formulations of sufentanil |
9 United States (US) Sufentanil Market - Opportunity Assessment |
9.1 United States (US) Sufentanil Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 United States (US) Sufentanil Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 United States (US) Sufentanil Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 United States (US) Sufentanil Market Opportunity Assessment, By Doses, 2021 & 2031F |
9.5 United States (US) Sufentanil Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.6 United States (US) Sufentanil Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Sufentanil Market - Competitive Landscape |
10.1 United States (US) Sufentanil Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Sufentanil Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here